Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab

Plitidepsin (Aplidin), an antitumor agent of marine origin, presently is undergoing phase II/III clinical trials, and has shown promise for the treatment of lymphoma. Here, we describe the antitumor effects of plitidepsin alone and in combination with rituximab and investigated the effects of each d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barboza, Nora M, Medina, Daniel J, Budak-Alpdogan, Tulin, Aracil, Miguel, Jimeno, José M, Bertino, Joseph R, Banerjee, Debabrata
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2012
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3336068/
https://ncbi.nlm.nih.gov/pubmed/22336911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.13.2.18876
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados